101 – 110 of 143
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers
Glodzik, Dominik LU ; Bosch, Ana LU ; Hartman, Johan ; Aine, Mattias LU ; Vallon-Christersson, Johan LU
; Reuterswärd, Christel
LU
; Karlsson, Anna
LU
; Mitra, Shamik
LU
; Niméus, Emma
LU
and Holm, Karolina
LU
, et al.
(2020)
In Nature Communications
11(1).
- Contribution to journal › Article
-
Mark
Simvastatin is a potential candidate drug in ovarian clear cell carcinomas
- Contribution to journal › Article
-
Mark
A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients
Leandersson, Pia LU
; Åkesson, Anna
LU
; Hedenfalk, Ingrid
LU
; Malander, Susanne
LU
and Borgfeldt, Christer
LU
(2020)
In PLoS ONE
15(10 October).
- Contribution to journal › Article
-
Mark
Analysis of fusion transcripts indicates widespread deregulation of snoRNAs and their host genes in breast cancer
Persson, Helena LU
; Søkilde, Rolf
LU
; Häkkinen, Jari
LU
; Vallon-Christersson, Johan
LU
; Mitelman, Felix
LU
; Borg, Åke
LU
; Höglund, Mattias
LU
and Rovira, Carlos
LU
(2020)
In International Journal of Cancer
146(12).
p.3343-3353
- Contribution to journal › Article
-
Mark
CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients
Kimbung, Siker LU ; Inasu, Maria LU ; Stålhammar, Tor ; Nodin, Björn LU ; Elebro, Karin LU ; Tryggvadottir, Helga LU ; Ygland Rödström, Maria ; Jirström, Karin LU
; Isaksson, Karolin
LU
and Jernström, Helena
LU
, et al.
(2020)
In Breast Cancer Research
22(1).
- Contribution to journal › Article
-
Mark
SOX2 is a promising predictor of relapse and death in advanced stage high-grade serous ovarian cancer patients with residual disease after debulking surgery
Bååth, Maria LU ; Westbom-Fremer, Sofia LU
; Martin de la Fuente, Laura
LU
; Ebbesson, Anna
LU
; Davis, Juliette
; Malander, Susanne
LU
; Måsbäck, Anna
LU
; Kannisto, Päivi
LU
and Hedenfalk, Ingrid
LU
(2020)
In Molecular and Cellular Oncology
7(6).
- Contribution to journal › Article
-
Mark
The mutational landscape of the SCAN‐B real‐world primary breast cancer transcriptome
Brueffer, Christian LU
; Gladchuk, Sergii
LU
; Winter, Christof
LU
; Vallon-Christersson, Johan
LU
; Hegardt, Cecilia
LU
; Häkkinen, Jari
LU
; George, Anthony
LU
; Chen, Yilun
LU
; Ehinger, Anna
LU
and Larsson, Christer
LU
, et al.
(2020)
In EMBO Molecular Medicine
12(10).
- Contribution to journal › Article
-
Mark
Auto-segmentations by convolutional neural network in cervical and anorectal cancer with clinical structure sets as the ground truth
Sartor, Hanna LU ; Minarik, David LU ; Enqvist, Olof LU ; Ulén, Johannes LU ; Wittrup, Anders LU ; Bjurberg, Maria LU and Trägårdh, Elin LU
(2020)
In Clinical and Translational Radiation Oncology
25.
p.37-45
- Contribution to journal › Article
-
Mark
Human G-MDSCs are neutrophils at distinct maturation stages promoting tumor growth in breast cancer
Mehmeti-Ajradini, Meliha LU ; Bergenfelz, Caroline LU
; Larsson, Anna Maria
LU
; Carlsson, Robert
LU
; Riesbeck, Kristian
LU
; Ahl, Jonas
LU
; Janols, Helena
LU
; Wullt, Marlene
LU
; Bredberg, Anders
LU
and Kallberg, Eva
LU
, et al.
(2020)
In Life Science Alliance
3(11).
- Contribution to journal › Article
-
Mark
Fine-tuning the metabolic rewiring and adaptation of translational machinery during an epithelial-mesenchymal transition in breast cancer cells
Fernández-Calero, Tamara ; Davyt, Marcos ; Perelmuter, Karen ; Chalar, Cora ; Bampi, Giovana ; Persson, Helena LU
; Tosar, Juan Pablo
; Hafstað, Völundur
LU
; Naya, Hugo
LU
and Rovira, Carlos
LU
, et al.
(2020)
In Cancer & Metabolism
8.
p.8-8
- Contribution to journal › Article